Browsing by Author "CREDENCE Study Investigators"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial(2019-08-27) CREDENCE Study Investigators; University of Aberdeen.Medicine, Medical Sciences & Nutrition
